STYLUS MEDICINE
LIVE

Serial Number

98110955

Owner

Stylus Medicine, Inc.

Attorney

Christie Baty Hudgins

Filing Date

Aug 1, 2023

Add to watchlist:

No watchlists yet
View on USPTO

STYLUS MEDICINE Trademark

Serial Number: 98110955

STYLUS MEDICINE is a trademark filed by Stylus Medicine, Inc. on August 1, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Stylus Medicine, Inc. (4 trademarks)

Suite 14-403
Cambridge, MA 02139

Entity Type: 03

Trademark Details

Filing Date

August 1, 2023

Registration Date

Not Registered

Published for Opposition

November 19, 2024

Goods & Services

Pharmaceutical preparations for gene therapy; pharmaceutical preparations that use genome editing to treat genetic, oncological, and immune system disorders and diseases

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 1, 2026 EXRA
SOU EXTENSION 3 GRANTED
Mar 31, 2026 EX3G
SOU EXTENSION 3 FILED
Mar 31, 2026 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 31, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 18, 2025 EXRA
SOU EXTENSION 2 GRANTED
Dec 17, 2025 EX2G
SOU EXTENSION 2 FILED
Dec 17, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 17, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 21, 2025 EXRA
SOU EXTENSION 1 GRANTED
Jun 20, 2025 EX1G
SOU EXTENSION 1 FILED
Jun 20, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 20, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 31, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 19, 2024 NPUB
PUBLISHED FOR OPPOSITION
Nov 19, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 13, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 11, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 7, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 7, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 7, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jul 2, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jul 2, 2024 XELR
NOTIFICATION OF PRIORITY ACTION E-MAILED
Apr 5, 2024 GPRN
PRIORITY ACTION E-MAILED
Apr 5, 2024 GPRA
PRIORITY ACTION WRITTEN
Apr 5, 2024 CPRA
ASSIGNED TO EXAMINER
Apr 2, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 30, 2023 NWOS
NEW APPLICATION ENTERED
Aug 4, 2023 NWAP